A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients for ...

A heart transplant recipient safely carried a baby to term using noninvasive DNA monitoring—marking a new milestone in maternal and transplant care.

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

Salivary cell-free mitochondrial DNA may serve as a non-invasive, low-cost biomarker for early Alzheimer’s detection before cognitive decline begins.

The Business Research Company's Cell-Free DNA (cfDNA) Blood Collection Tube Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 ...

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for ...